Broncho dilator response to salbutamol delivered by metered dose inhaler with spacer versus dry powder inhaler in acute asthma in children Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma Year: 2016
Metered dose inhaler with spacer versus nebulizer in children with acute bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 429s Year: 2002
Distribution of technetium-99m-labelled QVARTM delivered using an AutohalerTM device in children Source: Eur Respir J 2003; 21: 1007-1011 Year: 2003
Lung targeting of flunisolide is enhanced when delivered as an extra fine HFA aerosol with a built-in spacer Source: Eur Respir J 2001; 18: Suppl. 33, 70s Year: 2001
Bronchodilatation and systemic β2 -response measurement in asthmatic patients after using salbutamol comparing a metal and a plastic spacer Source: Eur Respir J 2001; 18: Suppl. 33, 99s Year: 2001
No age effect on systemic exposure to beclometasone and formoterol after pressurized metered dose inhalation in paediatric, adolescent and adult asthma Source: Annual Congress 2013 –Uncontrolled and severe asthma in children Year: 2013
Inhaler choice in primary practice Source: Eur Respir Rev 2005; 14: 117-122 Year: 2005
Do dry powder inhalers (DPIs) have a ‘Goldilocks Zone’ of inhalation? In vitro lung deposition of Budesonide/Formoterol (BUD/FORM) DPI with different inhalation profiles Source: International Congress 2017 – Pulmonary drug and devices delivery Year: 2017
The effect of inhalation duration on lung deposition with a pressurized metered-dose inhaler (pMDI) Source: International Congress 2014 – Asthma and COPD devices and treatments Year: 2014
Deposition of 99m Tc-HFA-BDP inhaled via pMDI-spacer in asthmatic children Source: Eur Respir J 2004; 24: Suppl. 48, 379s Year: 2004
Lung deposition of an aerosol produced by a new inhalation device for ventilated patients Source: Eur Respir J 2005; 26: Suppl. 49, 88s Year: 2005
In vitro lung deposition of fluticasone propionate/formoterol (FP/FORM) pressurized metered dose inhaler (pMDI) with different inhalation profiles Source: International Congress 2014 – Asthma and COPD devices and treatments Year: 2014
COPD and asthma patients are satisfied with handling and inhalation characteristics of Soft Mist InhalerÔ (Berodual® Respimat®) Source: Eur Respir J 2006; 28: Suppl. 50, 739s Year: 2006
Assessment of inhalation technique and satisfaction with inhalers in asthmatic patients Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies Year: 2020
Inhaler treatment options in COPD Source: Eur Respir Rev 2005; 14: 102-108 Year: 2005
The small airway inflammation of asthmatic patients who have used dry powder type inhaled steroid for moderate-long term evaluated by induced sputum and the efficacy of HFA-BDP (QVAR) inhalation Source: Eur Respir J 2005; 26: Suppl. 49, 503s Year: 2005
Comparison of FENO reduction in asthmatic children treated with inhaled budesonide-MDI with two-valved, non valved, or home-made spacers Source: Annual Congress 2007 - Anti-inflammatory therapy for childhood asthma Year: 2007
Comparison of bronchodilator effect of salbutamol delivered via MDI + spacer and DPI in children with asthma Source: Annual Congress 2012 - Clinical and diagnostic markers and management of paediatric allergic diseases Year: 2012
In vitro comparison of output and particle size distribution of budesonide from metered-dose inhaler with three spacer devices during pediatric tidal breathingSource: Eur Respir J 2005; 26: Suppl. 49, 161s Year: 2005
Increased asthma medication use in association with ambient fine and ultrafine particles Source: Eur Respir J 2002; 20: 691-702 Year: 2002